(1)
Weidinger, S.; Pink, A.; Francisco, J.; Kurbasic, A.; Olsen, C.; Vilsbøll, A.; de Bruin Weller, M. Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients With Moderate-To-Severe Atopic Dermatitis. J of Skin 2020, 4, s100.